Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraoperative radiotherapy (IORT) as boost in breast cancer.
Sedlmayer F, Reitsamer R, Wenz F, Sperk E, Fussl C, Kaiser J, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: sperk e. Radiat Oncol. 2017 Jan 19;12(1):23. doi: 10.1186/s13014-016-0749-9. Radiat Oncol. 2017. PMID: 28103903 Free PMC article. Review.
Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
Welzel G, Boch A, Sperk E, Hofmann F, Kraus-Tiefenbacher U, Gerhardt A, Suetterlin M, Wenz F. Welzel G, et al. Among authors: sperk e. Radiat Oncol. 2013 Jan 7;8:9. doi: 10.1186/1748-717X-8-9. Radiat Oncol. 2013. PMID: 23294485 Free PMC article. Clinical Trial.
Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database.
Krengli M, Calvo FA, Sedlmayer F, Sole CV, Fastner G, Alessandro M, Maluta S, Corvò R, Sperk E, Litoborski M, Pisani C, Fillini C, Fusconi F, Osti MF, Tomio L, Marsiglia H, Ciabattoni A, Polkowski W, Di Grazia A, Gava A, Kuten A, Iotti C, Gonzalez C, Sallabanda M, Dubois JB, Catalano G, Valentini V. Krengli M, et al. Among authors: sperk e. Strahlenther Onkol. 2013 Sep;189(9):729-37. doi: 10.1007/s00066-013-0395-1. Epub 2013 Jul 12. Strahlenther Onkol. 2013. PMID: 23842635
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Sütterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M; TARGIT trialists' group. Vaidya JS, et al. Among authors: sperk e. Lancet. 2014 Feb 15;383(9917):603-13. doi: 10.1016/S0140-6736(13)61950-9. Epub 2013 Nov 11. Lancet. 2014. PMID: 24224997 Free article. Clinical Trial.
Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.
Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, Giordano FA, Herskind C, Steil V, Wenz F, Glatting G. Abo-Madyan Y, et al. Among authors: sperk e. Radiother Oncol. 2014 Mar;110(3):471-6. doi: 10.1016/j.radonc.2013.12.002. Epub 2014 Jan 17. Radiother Oncol. 2014. PMID: 24444525
78 results